KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Tax Provisions (2021 - 2025)

Pacific Biosciences Of California (PACB) has 4 years of Tax Provisions data on record, last reported at $202000.0 in Q4 2025.

  • For Q4 2025, Tax Provisions fell 36.08% year-over-year to $202000.0; the TTM value through Dec 2025 reached $318000.0, up 0.63%, while the annual FY2025 figure was $318000.0, 0.63% up from the prior year.
  • Tax Provisions reached $202000.0 in Q4 2025 per PACB's latest filing, down from $383000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $1.2 million in Q4 2021 and bottomed at -$94.8 million in Q3 2021.
  • Average Tax Provisions over 4 years is -$11.6 million, with a median of $35000.0 recorded in 2025.
  • Peak YoY movement for Tax Provisions: soared 144.01% in 2024, then crashed 36.08% in 2025.
  • A 4-year view of Tax Provisions shows it stood at $1.2 million in 2021, then plummeted by 161.11% to -$718000.0 in 2023, then skyrocketed by 144.01% to $316000.0 in 2024, then crashed by 36.08% to $202000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Tax Provisions were $202000.0 in Q4 2025, $383000.0 in Q3 2025, and $35000.0 in Q2 2025.